Genpact Limited
NYSE:GInformation Technology Services
-$2.73 today
- Market cap
- $7.12B
- Beta
- 0.59
- P/E (TTM)
- 8.2
- EPS (TTM)
- $3.34
- Dividend yield
- 2.59%
Volume 2.37M
Average 2.81M
G Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Genpact LimitedNYSE: G
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How G compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for G, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $446.07M USD | +3.2% | -1.8% | 21.8% | |
| LTM Sep 2026 | $262.78M USD | +0.4% | -1.1% | 18.5% | |
| LTM Jun 2026 | $67.01M USD | +44.9% | +18.5% | 5.6% | |
| LTM Jun 2026 | CN¥32.59M CNY | +1.2% | -3.0% | 0.3% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Jul 2026 | $0 USD | — | — | 0.0% | |
INGMIngram Micro Holding Corporation | LTM Jun 2026 | $0 USD | — | — | 0.0% |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jul 2026 | $0 USD | — | +184.4% | 0.0% | |
| LTM Jun 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding G) | — | +1.2% | -1.1% | 0.0% | |
Competitors are the stored peer set for G. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 4.02B | 4.37B | 4.48B | 4.77B | 5.08B |
| Cost of Revenue | 2.59B | 2.83B | 2.91B | 3.08B | 3.27B |
| Gross Profit | 1.43B | 1.54B | 1.57B | 1.69B | 1.81B |
| Gross Margin | 35.6% | 35.1% | 35.1% | 35.5% | 35.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 865.72M | 938.39M | 913.06M | 967.15M | 1.05B |
| Operating Expenses | 922.96M | 1.03B | 939.81M | 988.01M | 1.05B |
| Depreciation & Amortization | 167.57M | 129.52M | 103.99M | 69.78M | 94.96M |
| EBITDA | 709.01M | 652.86M | 772.53M | 826.11M | 874.7M |
| EBITDA Margin | 17.6% | 14.9% | 17.3% | 17.3% | 17.2% |
| Operating Income | 509M | 502.15M | 630.86M | 702.06M | 760.01M |
| Operating Margin | 12.7% | 11.5% | 14.1% | 14.7% | 15.0% |
| Interest Income | 6.88M | 5.9M | 18.37M | 32.29M | 23.92M |
| Interest Expense | 58.31M | 58.1M | 66.31M | 79.51M | 73.52M |
| Other Income / Expenses | (25.87M) | (36.92M) | (28.63M) | (25.24M) | (29.86M) |
| Income Before Tax | 483.13M | 465.24M | 602.22M | 676.82M | 730.15M |
| Pre-Tax Margin | 12.0% | 10.6% | 13.5% | 14.2% | 14.4% |
| Income Tax Expense | 113.68M | 111.83M | (29.03M) | 163.15M | 177.65M |
| Net Income | 369.45M | 353.4M | 631.26M | 513.67M | 552.49M |
| Net Margin | 9.2% | 8.1% | 14.1% | 10.8% | 10.9% |
| EPS (Basic) | 1.97 | 1.92 | 3.46 | 2.88 | 3.18 |
| EPS (Diluted) | 1.91 | 1.88 | 3.41 | 2.85 | 3.13 |
| Weighted Avg Shares | 187.8M | 184.18M | 182.35M | 178.39M | 173.89M |
| Weighted Avg Shares (Diluted) | 192.96M | 188.09M | 185.14M | 180.44M | 176.65M |
Genpact Limited
NYSE:G
Intrinsic Alpha fair value
Locked
Current Price
$41.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.